Topoisomerase activities in undifferentiated acute myeloblastic leukemias and monocytic differentiated leukemias.
Medizinische Poliklinik, University of Würzburg, Germany.
F
F
Gieseler
A
A
Glasmacher
D
D
Kämpfe
C
C
Zernak
S
S
Valsamas
J
J
Kunze
M
M
Clark
D001853:Bone Marrow / Q000201:enzymology / Q000473:pathology; D004250:DNA Topoisomerases, Type II / Q000097:blood / Q000378:metabolism*; D003630:Daunorubicin / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005047:Etoposide / Q000494:pharmacology; D006801:Humans; D015255:Idarubicin / Q000494:pharmacology; D007948:Leukemia, Monocytic, Acute / Q000097:blood / Q000201:enzymology* / Q000473:pathology; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000201:enzymology* / Q000473:pathology; D059005:Topoisomerase II Inhibitors
D004791:Enzyme Inhibitors; D059005:Topoisomerase II Inhibitors; D005047:Etoposide; D004250:DNA Topoisomerases, Type II; D015255:Idarubicin; D003630:Daunorubicin